Immunization, measles in Europe & Central Asia (IDA & IBRD countries)
Europe & Central Asia (IDA & IBRD countries): Immunization, measles was 94.3% in 2024. ▲ Rising
Immunization, measles in Europe & Central Asia (IDA & IBRD countries), 1992–2024
Source: World Health Organization (WHO). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, measles in Europe & Central Asia (IDA & IBRD countries) stood at 94.3%.
Compared with earlier readings it is down 0.4% on the previous year and up 1.4% over ten years.
Over the whole period, immunization, measles in Europe & Central Asia (IDA & IBRD countries) peaked at 96.6% in 2008 and was at its lowest, 82.3%, in 1994.
That places Europe & Central Asia (IDA & IBRD countries) 6th out of 47 groups with data for 2024, putting it in the top quarter.
The long-run direction has been consistently rising across the 33 years of available data.
Immunization, measles in Europe & Central Asia (IDA & IBRD countries), year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1992 | 82.4% | — |
| 1993 | 83.7% | +1.5% |
| 1994 | 82.3% | -1.7% |
| 1995 | 83.4% | +1.3% |
| 1996 | 86.3% | +3.4% |
| 1997 | 89.6% | +3.8% |
| 1998 | 90.5% | +1.0% |
| 1999 | 91.6% | +1.2% |
| 2000 | 93.3% | +1.9% |
| 2001 | 94.4% | +1.1% |
| 2002 | 92.4% | -2.1% |
| 2003 | 91.0% | -1.5% |
| 2004 | 92.7% | +1.9% |
| 2005 | 95.3% | +2.7% |
| 2006 | 96.5% | +1.4% |
| 2007 | 96.6% | +0.0% |
| 2008 | 96.6% | +0.0% |
| 2009 | 94.7% | -2.0% |
| 2010 | 93.8% | -0.9% |
| 2011 | 95.0% | +1.2% |
| 2012 | 95.3% | +0.3% |
| 2013 | 95.7% | +0.5% |
| 2014 | 93.0% | -2.9% |
| 2015 | 93.6% | +0.7% |
| 2016 | 92.7% | -0.9% |
| 2017 | 95.4% | +2.9% |
| 2018 | 95.5% | +0.1% |
| 2019 | 96.1% | +0.7% |
| 2020 | 93.5% | -2.7% |
| 2021 | 94.1% | +0.6% |
| 2022 | 93.7% | -0.5% |
| 2023 | 94.7% | +1.1% |
| 2024 | 94.3% | -0.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 86.2% | 82.3% | 91.6% | 8 |
| 2000s | 94.4% | 91.0% | 96.6% | 10 |
| 2010s | 94.6% | 92.7% | 96.1% | 10 |
| 2020s | 94.1% | 93.5% | 94.7% | 5 |
More health data for Europe & Central Asia (IDA & IBRD countries)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0402 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -0.0639 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1882 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.035 units per person (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, measles in Europe & Central Asia (IDA & IBRD countries)?
- Immunization, measles in Europe & Central Asia (IDA & IBRD countries) was 94.3% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, measles recorded in Europe & Central Asia (IDA & IBRD countries)?
- The highest recorded value was 96.6% in 2008.
- What is the lowest immunization, measles recorded in Europe & Central Asia (IDA & IBRD countries)?
- The lowest recorded value was 82.3% in 1994.
- How does Europe & Central Asia (IDA & IBRD countries) rank for immunization, measles?
- Europe & Central Asia (IDA & IBRD countries) ranks 6th out of 47 groups with data for 2024.
- Is immunization, measles rising or falling in Europe & Central Asia (IDA & IBRD countries)?
- Over the last ten years it is up 1.4%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, measles (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.